Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Biofrontera Inc

BFRI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$1.56

▼ -3.11%

Market Cap $23.17M · Vol 105.58K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$23.17M

Micro Cap

Div Yield

N/A

EPS Growth

+63.46%

YoY

RSI (14)

60.91

Momentum

Beta

0.84

vs Market

52W High

$1.65

5.45% below

52W Low

$0.55

181.23% above

Volume

105.58K

Avg 93.61K

P/B

0.63

Price-to-book

ROE

N/A

Return on equity

Free Float

83.29%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Biofrontera Inc (BFRI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BFRI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.96%

+22.83%

+67.74%

+81.61%

YTD

+173.68%

+92.59%

-81.65%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$41.71M
Net Income	$-10,536,000.00
Revenue Growth (YoY)	+32.92%
Gross Margin	73.71%
Operating Margin	-27.21%
Net Profit Margin	-25.26%
ROE	N/A
ROA · ROIC	-41.49% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.14
P/B	0.63
P/FCF	N/A
EPS Growth	+63.46%
Outstanding Shares	14.85M

Technical Indicators

50-Day SMA	$1.25
200-Day SMA	$0.98
RSI (14)	60.91
Beta	0.84
52-Week High	$1.65
52-Week Low	$0.55

Volume Today	105.58K
Avg Daily Volume (30D)	93.61K
Relative Volume	1.13x
Volatility (10D)	55.96
Volatility (30D)	51.49
Free Float	83.29%

Analyst Consensus

BUY

Current Price $1.56

Mean Target $9.00

52W Low$0.55 52W High$1.65

Current

Target

$0.55 $1.65

Current Analyst target

+476.92% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00HTD0PY9

ISINUS09077D2099

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.21% JNJ Johnson & Johnson -2.22% ABBV Abbvie Inc -2.99% NVS Novartis AG -13.93% NOVN.S Novartis AG -10.89%

Company Profile

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.